Amgen, Inc. (AMGN) Misses Q1 EPS by 7c

Amgen, Inc. (NASDAQ: AMGN) reported Q1 EPS of $1.87, $0.07 worse than the analyst estimate of $1.94. Revenue for the quarter came in at $4.52 billion versus the consensus estimate of $4.76 billion.

For earnings history and earnings-related data on Amgen, Inc. (AMGN) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Taylor Devices (TAYD) Misses Q4 EPS by 31c
• TD Cowen Reiterates Buy Rating on NVIDIA (NVDA), 'unlikely to move significantly on earnings'